Other languages RaQualia Pharma Inc.

Equities

4579

JP3967150008

Market Closed - Japan Exchange Other stock markets 11:30:00 15/05/2024 am IST			5-day change	1st Jan Change
583 ^JPY	-2.51%		-4.27%	-15.26%

26/03	RaQualia Pharma Inc. completed the acquisition of FIMECS, Inc. from Yusuke Tominari, Kamakanae, Nissay Capital No. 11 Investment Limited Partnership managed by Nissay Capital Co., Ltd., ANRI No. 4 Fund managed by ANRI and others.	CI
14/02	RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RaQualia Pharma Inc. completed the acquisition of FIMECS, Inc. from Yusuke Tominari, Kamakanae, Nissay Capital No. 11 Investment Limited Partnership managed by Nissay Capital Co., Ltd., ANRI No. 4 Fund managed by ANRI and others.	26/03
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2024	14/02
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2023	10/23/10
RaQualia Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2023	15/23/15
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2023	14/23/14
Raqualia Pharma Inc. Provides Consolidated Earnings Guidance for Year Ending December 31, 2022	11/22/11
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022	15/22/15
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2022	15/22/15
RaQualia Pharma Inc. Provides Earnings Guidance for the Year Ending December 31, 2021	12/21/12
Raqualia Pharma Inc. Provides Consolidated Earnings Guidance for the Full Year Ending December 31, 2021	12/21/12
RaQualia Pharma Inc. Announces Consolidated Financial Results for the Six Months Ended June 30, 2021	12/21/12
RaQualia Pharma Inc. Announces Consolidated Earnings Results for the First Quarter Ended March 31, 2021	14/21/14
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2021	14/21/14
RaQualia Pharma Inc. Provides Earnings Guidance for the Year Ending December 31, 2021	12/21/12
RaQualia Pharma Inc. Announces Consolidated Earnings Results for the Year Ended December 31, 2020	12/21/12
RaQualia Pharma Inc. Announces Consolidated Financial Results for the Nine Months Ended September 30, 2020	13/20/13
RaQualia Pharma Inc. Provides Financial Guidance for the Fiscal Year Ending December 31, 2020	13/20/13
RaQualia Pharma Inc. Revises Earnings Guidance for the Full Year Ended December 31, 2020	14/20/14
RaQualia Pharma Inc. Announces Consolidated Financial Results for the Six Months Ended June 30, 2020	14/20/14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages RaQualia Pharma Inc.

Equities

4579

JP3967150008

Other languages

Filters